MALIGNANCY RISK IN AUSTRALIAN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR THERAPY: AN UPDATE FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD) PROSPECTIVE COHORT STUDY

被引：0
|
作者：
Staples, M. [1 ]
Lassere, M. [2 ]
March, L. [3 ]
Hill, C. [4 ]
Buchbinder, R. [5 ]
机构：
[1] Cabrini Hlth, Malvern, Vic, Australia
[2] St George Hosp, Kogarah, NSW, Australia
[3] Royal North Shore Hosp, St Leonards, NSW, Australia
[4] Queen Elizabeth Hosp, Woodville, SA, Australia
[5] Monash Univ, Clayton, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O-14
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study
    Margaret P. Staples
    Lyn March
    Catherine Hill
    Marissa Lassere
    Rachelle Buchbinder
    [J]. BMC Rheumatology, 3
  • [2] Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study
    Staples, Margaret P.
    March, Lyn
    Hill, Catherine
    Lassere, Marissa
    Buchbinder, Rachelle
    [J]. BMC RHEUMATOLOGY, 2019, 3 (01)
  • [3] Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study
    Rachelle Buchbinder
    Sharon Van Doornum
    Margaret Staples
    Marissa Lassere
    Lyn March
    [J]. BMC Musculoskeletal Disorders, 16
  • [4] Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study
    Buchbinder, Rachelle
    Van Doornum, Sharon
    Staples, Margaret
    Lassere, Marissa
    March, Lyn
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [5] Risk of Malignancy in Australian Rheumatoid Arthritis Patients Treated with Tumour Necrosis Factor Inhibitors.
    Van Doornum, Sharon
    Staples, Margaret P.
    March, Lynette
    Lassere, Marissa N.
    Buchbinder, Rachelle
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S154 - S154
  • [6] RISK AND PREDICTORS OF HOSPITALISATION IN RHEUMATOID ARTHRITIS PATIENTS ON BIOLOGICAL THERAPIES: RESULTS FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD)
    Williams, B.
    March, L.
    Buchbinder, R.
    Reid, C.
    Staples, M.
    Lassere, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 : 17 - 17
  • [7] Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety
    Hyrich, KL
    Silman, AJ
    Watson, KD
    Symmons, DPM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1538 - 1543
  • [8] Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database
    Staples, Margaret P.
    March, Lyn
    Lassere, Marissa
    Reid, Chris
    Buchbinder, Rachelle
    [J]. RHEUMATOLOGY, 2011, 50 (01) : 166 - 175
  • [9] Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
    Raaschou, Pauline
    Simard, Julia F.
    Holmqvist, Marie
    Askling, Johan
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [10] BASELINE CHARACTERISTICS OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD)
    Sinnathurai, P.
    Lassere, M.
    Buchbinder, R.
    March, L.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 : 43 - 43
12345